CYP2C93: A New Drug-Metabolizing Enzyme in Rhesus Monkeys
Author Information
Author(s): Uno Yasuhiro, Uehara Shotaro, Kohara Sakae, Iwasaki Kazuhide, Nagata Ryoichi, Fukuzaki Koichiro, Utoh Masahiro, Murayama Norie, Yamazaki Hiroshi
Primary Institution: Shin Nippon Biomedical Laboratories, Ltd.
Hypothesis
CYP2C93 is a functional enzyme in rhesus monkeys but not in cynomolgus monkeys.
Conclusion
CYP2C93 is predominantly expressed in the liver of rhesus monkeys and can metabolize several human CYP2C substrates.
Supporting Evidence
- CYP2C93 mRNA was predominantly expressed in the liver among various tissues analyzed.
- CYP2C93 proteins metabolized human CYP2C substrates like diclofenac and flurbiprofen.
- Functional transcript variant SV1 was found in 6 of 11 rhesus monkeys.
- All analyzed cynomolgus monkeys expressed a nonfunctional variant of CYP2C93.
Takeaway
Researchers found a new enzyme in rhesus monkeys that helps break down certain drugs, but this enzyme doesn't work in a similar monkey species.
Methodology
The study involved cloning and characterizing CYP2C93 cDNA from liver tissues of cynomolgus and rhesus monkeys, followed by enzyme activity assays.
Potential Biases
Potential bias due to the authors' affiliation with a biomedical laboratory that may have vested interests in the findings.
Limitations
The study primarily focused on two monkey species, limiting the generalizability of findings to other species.
Participant Demographics
The study included 11 rhesus monkeys and 8 cynomolgus monkeys, with both male and female subjects.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website